The company has repeatedly stated they would only want to disclose TLD in coordinated with a scientific publication. DI has said publication has a usual timeframe of mOS 14 months after data lock but is now confronted with a few months delay because of Covid. So Oct 5 2020 + 14 months is Dec 5 2021 + 2 months delay is…. Exactly
If you look at the history of DCVAX L trial you will understand NWBO has a LOT of positive explaining todo pseudo progression, endpoint change, GBM definition change by WHO and thus its incredible understandable they want to coordinate TLD with a publication. IMO if they had disclosed TLD in Nov 2020 then A. Medical KOLs (and not shorts or AF) would have asked many understandable questions left unanswered and B. They had to recalculate and again disclose TLD after WHO redefined GBM
The SP decline is warrant holders that have haven exercised and selling because of profit taken after nothing had happened after SNO AND NWBO letting these warrant holders exercise. Remember NWBO did manage warrant holders NOT to exercise for almost 1 year but that cat has been left out of the out of the bag now by NWBO. Also the risc off market and biotech down does not help either. All IMO
Market Data 
Markets 
AI
